Synercid-Induced Myalgias;Another Allergic Reaction to Methylprednisolone;More on Heparin Flush–Induced Thrombocytopenia;Hiccups and Steroid Injections;Topical Tricyclic Toxicity?;Priapism with OTC Hormonal Agent;Quinine-induced Thrombocytopenia and Neutropenia;Hyperventilation and Quetiapine
Restricted accessResearch articleFirst published online June, 2000
Synercid-Induced Myalgias;Another Allergic Reaction to Methylprednisolone;More on Heparin Flush–Induced Thrombocytopenia;Hiccups and Steroid Injections;Topical Tricyclic Toxicity?;Priapism with OTC Hormonal Agent;Quinine-induced Thrombocytopenia and Neutropenia;Hyperventilation and Quetiapine
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
LowD.E.Quinupristin/dalfopristin: Spectrum of activity, pharmacokinetics, and initial clinical experience. Microbiol Drug Resistance.1995; 1: 223.
2.
RubinsteinE., ProocimerP., TalbotG.H.Safety and tolerability of quinupristin/dalfopristin: Administration guidelines. J Antimicrob Chem.1999; 44: Topic A, 37.
